The Non-Alcoholic Steatohepatitis Supplement Market size was USD 762.4 million in 2022 and is expected to Reach USD 1019.5 million by 2030 and grow at a CAGR of 3.7 % over the forecast period of 2023-2030.
Non-alcoholic steatohepatitis (NASH) is a liver disease that causes inflammation and scarring as a result of fat accumulation that affects millions of individuals worldwide. NASH is also linked to an increased risk of cardiovascular disease and other metabolic illnesses, with sedentary lifestyles being the root reason.
The European Liver Patients Association (ELPA) brought together the EU NASH Summit on June 2023, in the European Parliament to increase awareness and develop interaction among stakeholders on this public health concern. People with NASH are susceptible to liver fibrosis, which can progress to cirrhosis, placing them at high risk of death from liver failure or malignancy. As a result, the region's need for non-alcoholic steatohepatitis supplements has soared. As a result of the aforementioned factors, the Asia-Pacific region accounted for the biggest market share throughout the forecast period.
KEY DRIVERS
Increasing initiatives to promote awareness of NASH
The market for NASH supplements is still in its early stages, and many consumers may be not aware of the possible benefits of taking supplements. NASH and its symptoms are made more widely known through public education programs. They also offer information on available treatments, such as NASH supplements. Overall, growing awareness about the potential advantages of NASH supplements among patients and healthcare professionals is encouraging their usage in the treatment of NASH and related metabolic disorders. To ensure safe and efficient use, supplements should be used in tandem with other lifestyle changes under the supervision of a healthcare practitioner.
RESTRAIN
Side-effects of NASH Supplements
Like any other medicine, NASH supplements may cause undesired side effects or interfere with other medications. High doses of vitamin E supplements, for example, may increase the risk of bleeding in individuals on blood thinners, and omega-3 fatty acid supplements might interact with certain cholesterol-reducing drugs. Furthermore, supplement safety and efficacy may vary depending on every patient's medical condition and other medications they might be consuming.
Lack of awareness of potential benefits of NASH supplements
OPPORTUNITY
Research & Development in NASH Supplements
NASH is a severe type of fatty liver disease that can cause serious liver damage and have a significant influence on overall health. There is an increase in investment in R&D activities for improved treatment of NASH illnesses. Future research is needed to further investigate the causes of NASH so that medicines can help reverse the underlying mechanisms. There are no effective treatments for NASH at the moment, however, a new study discovered that folate and vitamin B12 could help reduce scarring and inflammation in human patients and animal models.
CHALLENGES
The high cost of some NASH supplements
The high cost of NASH supplements is attributed to a variety of variables, including manufacturing costs and the high expense of developing and testing novel supplements. This makes NASH supplements costlier, especially when taken for an extended period of time. This can make them expensive for certain consumers, particularly those who are already burdened financially by other medical bills.
Russia Ukraine has destroyed the healthcare system in Ukraine. More than 6.1 million people have been displaced by the war, many of whom are now living in cramped, unhygienic conditions, increasing their risk of getting diseases like hepatitis A and E, which can cause liver damage. Healthcare services have been affected by the war as well, making it challenging for those with liver illnesses to access the care they require. Also, the disruption in the supply chain of any medication like NASH supplement may delay the treatment of diseases. Many hospitals were damaged in Ukraine and people migrated to Europe fueling a humanitarian crisis with lasting effects. This might worsen the severity of liver disease consequences such as cirrhosis and hepatocellular cancer. There is a stagnant demand for NASH supplements but disruption in supply and war may impede market growth.
Despite the recession, people require critical disease medical treatment but to save money, people forgo medical attention for non-life-threatening diseases and minor disorders. Patients are concerned because they don’t have enough money to pay their medical expenditures. The number of patients who failed to show up for their appointments increased dramatically during the recession. The number of persons experiencing severe stress symptoms has increased, it is expected to rise in the aftermath of a recession as people cope with stress and financial difficulty. As consumers cut down on health supplements their consumption of NASH supplements decreases.
By Type
Probiotics
Pre-biotic
Synbiotics
Postbiotic
By Supplement Form
Tablet
Capsule
Powder
Others
By Nutrition
Milk thistle
Turmeric
Vitamin E
Omega-3-fatty acids
.png)
Asia-Pacific region will hold the biggest market share in 2022. The rising prevalence of obesity, rising NASH incidence, and increased product launches will fuel the region's growth during the projection period. For example, in many Asian countries, including South Korea, the obesity epidemic is on the increase, as is NAFLD. People with obesity or diabetes mellitus possess a higher prevalence of NAFLD than the overall population.
North America is growing as a market for NASH supplements because people are more aware of the possible health advantages of supplements and are turning to them to maintain their health and avoid disease. NAFLD is the most frequent chronic liver ailment in the United States, according to the American Liver Foundation 2022. It is estimated that approximately 25% of adults in the United States have NAFLD. NASH affects approximately 20% of persons with NAFLD (5% of adults in the United States).
Europe is expected to expand as a market for NASH supplements. NASH affects 10 million people or 18% of the Europe population, and its prevalence is anticipated to rise by more than 40% by 2030. Consumers become more aware of the possible health advantages of supplements, and many are turning to supplements to manage their health and avoid disease. NASH is becoming more common in Europe, and its incidence is projected to rise further in the future years.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Some key players are Nature's Bounty (Nestlé), NOW Foods, Herbalife International of America, Inc., DANONE S.A., ADM, Irwin Naturals, Oregon's Wild Harvest, Jarrow Formulas, Inc, Gaia Herbs and Nutra-Life Australia, Intercept Pharmaceuticals, Inc., Evogen Nutrition, and other key players.
In 2023, Intercept Pharmaceuticals, Inc. announced a restructuring to improve the Company's focus on rare and critical liver disorders while dramatically reducing operating expenses, including the discontinuation of all nonalcoholic steatohepatitis (NASH)-related funding.
In 2023, Nestlé introduced Nature's Bounty in the Philippines, a line of five non-GMO (genetically modified organism) supplements with no artificial flavors, colors, or sweeteners.
In 2023, Evogen Nutrition, a pioneer in sports nutrition and supplements, introduced a new liver support supplement designed to improve liver health and performance.
| Report Attributes | Details |
| Market Size in 2022 | US$ 762.4 Million |
| Market Size by 2030 | US$ 1019.5 Million |
| CAGR | CAGR of 3.7 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Probiotics, Synbiotics, Pre-biotic, Postbiotic) • By Supplement Form (Tablet, Capsule, Powder, Others) • By Nutrition (Milk thistle, Turmeric, Vitamin E, Omega-3-fatty acids) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Nature's Bounty (Nestlé), NOW Foods, Herbalife International of America, Inc., DANONE S.A., ADM, Irwin Naturals, Oregon's Wild Harvest, Jarrow Formulas, Inc, Gaia Herbs and Nutra-Life Australia, Intercept Pharmaceuticals, Inc., Evogen Nutrition |
| Key Drivers | • Increasing initiatives to promote awareness of NASH |
| Market Restrain | • Side-effects of NASH Supplements |
Ans: Non-Alcoholic Steatohepatitis Supplement Market is anticipated to expand by 3.7 % from 2023 to 2030.
Ans: Drivers are increasing initiatives to promote awareness of NASH.
Ans: USD 1019.5 million is expected to grow by 2030.
Ans: The Asia Pacific region dominated the Non-Alcoholic Steatohepatitis Supplement Market.
Ans: Challenges are lack of awareness of potential benefits and side-effects of NASH Supplements.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Non-Alcoholic Steatohepatitis Supplement Market Segmentation, By Type
8.1 Probiotics
8.2 Pre-biotic
8.3 Synbiotics
8.4 Postbiotic
9. Non-Alcoholic Steatohepatitis Supplement Market Segmentation, By Supplement Form
9.1 Tablet
9.2 Capsule
9.3 Powder
9.4 Others
10. Non-Alcoholic Steatohepatitis Supplement Market Segmentation, By Nutrition
10.1 Milk thistle
10.2 Turmeric
10.3 Vitamin E
10.4 Omega-3-fatty acids
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Non-Alcoholic Steatohepatitis Supplement Market by Country
11.2.2 North America Non-Alcoholic Steatohepatitis Supplement Market by Type
11.2.3 North America Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.2.4 North America Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.2.5 USA
11.2.5.1 USA Non-Alcoholic Steatohepatitis Supplement Market by Type
11.2.5.2 USA Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.2.5.3 USA Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.2.6 Canada
11.2.6.1 Canada Non-Alcoholic Steatohepatitis Supplement Market by Type
11.2.6.2 Canada Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.2.6.3 Canada Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.2.7 Mexico
11.2.7.1 Mexico Non-Alcoholic Steatohepatitis Supplement Market by Type
11.2.7.2 Mexico Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.2.7.3 Mexico Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Non-Alcoholic Steatohepatitis Supplement Market by Country
11.3.1.2 Eastern Europe Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.1.3 Eastern Europe Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.1.4 Eastern Europe Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.1.5 Poland
11.3.1.5.1 Poland Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.1.5.2 Poland Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.1.5.3 Poland Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.1.6 Romania
11.3.1.6.1 Romania Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.1.6.2 Romania Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.1.6.4 Romania Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.1.7 Turkey
11.3.1.7.1 Turkey Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.1.7.2 Turkey Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.1.7.3 Turkey Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.1.8.2 Rest of Eastern Europe Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.1.8.3 Rest of Eastern Europe Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2 Western Europe
11.3.2.1 Western Europe Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.2 Western Europe Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.3 Western Europe Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.4 Germany
11.3.2.4.1 Germany Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.4.2 Germany Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.4.3 Germany Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.5 France
11.3.2.5.1 France Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.5.2 France Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.5.3 France Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.6 UK
11.3.2.6.1 UK Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.6.2 UK Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.6.3 UK Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.7 Italy
11.3.2.7.1 Italy Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.7.2 Italy Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.7.3 Italy Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.8 Spain
11.3.2.8.1 Spain Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.8.2 Spain Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.8.3 Spain Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.9.2 Netherlands Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.9.3 Netherlands Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.10.2 Switzerland Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.10.3 Switzerland Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.11.1 Austria
11.3.2.11.2 Austria Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.11.3 Austria Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.11.4 Austria Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Non-Alcoholic Steatohepatitis Supplement Market by Type
11.3.2.12.2 Rest of Western Europe Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.3.2.12.3 Rest of Western Europe Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4 Asia-Pacific
11.4.1 Asia-Pacific Non-Alcoholic Steatohepatitis Supplement Market by Country
11.4.2 Asia-Pacific Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.3 Asia-Pacific Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.4 Asia-Pacific Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4.5 China
11.4.5.1 China Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.5.2 China Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4.5.3 China Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.6 India
11.4.6.1 India Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.6.2 India Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.6.3 India Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4.7 Japan
11.4.7.1 Japan Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.7.2 Japan Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.7.3 Japan Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4.8 South Korea
11.4.8.1 South Korea Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.8.2 South Korea Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.8.3 South Korea Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4.9 Vietnam
11.4.9.1 Vietnam Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.9.2 Vietnam Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.9.3 Vietnam Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4.10 Singapore
11.4.10.1 Singapore Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.10.2 Singapore Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.10.3 Singapore Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4.11 Australia
11.4.11.1 Australia Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.11.2 Australia Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.11.3 Australia Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Non-Alcoholic Steatohepatitis Supplement Market by Type
11.4.12.2 Rest of Asia-Pacific Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.4.12.3 Rest of Asia-Pacific Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Non-Alcoholic Steatohepatitis Supplement Market by Country
11.5.1.2 Middle East Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.1.3 Middle East Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.1.4 Middle East Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.1.5 UAE
11.5.1.5.1 UAE Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.1.5.2 UAE Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.1.5.3 UAE Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.1.6 Egypt
11.5.1.6.1 Egypt Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.1.6.2 Egypt Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.1.6.3 Egypt Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.1.7.2 Saudi Arabia Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.1.7.3 Saudi Arabia Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.1.8 Qatar
11.5.1.8.1 Qatar Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.1.8.2 Qatar Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.1.8.3 Qatar Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.1.9.2 Rest of Middle East Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.1.9.3 Rest of Middle East Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.2 Africa
11.5.2.1 Africa Non-Alcoholic Steatohepatitis Supplement Market by Country
11.5.2.2 Africa Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.2.3 Africa Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.2.4 Africa Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.2.5.2 Nigeria Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.2.5.3 Nigeria Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.2.6 South Africa
11.5.2.6.1 South Africa Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.2.6.2 South Africa Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.2.6.3 South Africa Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Non-Alcoholic Steatohepatitis Supplement Market by Type
11.5.2.7.2 Rest of Africa Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.5.2.7.3 Rest of Africa Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.6 Latin America
11.6.1 Latin America Non-Alcoholic Steatohepatitis Supplement Market by Country
11.6.2 Latin America Non-Alcoholic Steatohepatitis Supplement Market by Type
11.6.3 Latin America Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.6.4 Latin America Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.6.5 Brazil
11.6.5.1 Brazil Non-Alcoholic Steatohepatitis Supplement Market by Type
11.6.5.2 Brazil Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.6.5.3 Brazil Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.6.6 Argentina
11.6.6.1 Argentina Non-Alcoholic Steatohepatitis Supplement Market by Type
11.6.6.2 Argentina Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.6.6.3 Argentina Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.6.7 Colombia
11.6.7.1 Colombia Non-Alcoholic Steatohepatitis Supplement Market by Type
11.6.7.2 Colombia Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.6.7.3 Colombia Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Non-Alcoholic Steatohepatitis Supplement Market by Type
11.6.8.2 Rest of Latin America Non-Alcoholic Steatohepatitis Supplement Market by Supplement Form
11.6.8.3 Rest of Latin America Non-Alcoholic Steatohepatitis Supplement Market by Nutrition
12. Company profile
12.1 Nature's Bounty
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 NOW Foods
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 DANONE S.A.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 ADM
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Herbalife International of America Inc
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Irwin Naturals
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Jarrow Formulas
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Oregon's Wild Harvest
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Gaia Herbs
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Nutra-Life Australia
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
12.11 Intercept Pharmaceuticals, Inc.
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Product/Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
12.11 Intercept Pharmaceuticals, Inc.
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Product/Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
12.12 Evogen Nutrition
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Product/Services Offered
12.12.4 SWOT Analysis
12.12.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Frozen Desserts Market Size was esteemed at USD 91.98 billion out of 2022 and is supposed to arrive at USD 147.47 billion by 2030 and develop at a CAGR of 6.1% over the forecast period 2023-2030.
The Digestive Health Products Market Size was esteemed at USD 47.60 billion in 2022 and is supposed to arrive at USD 89.69 billion by 2030 and develop at a CAGR of 7.95 % over the forecast period 2023-2030.
The Mushroom Market Size was esteemed at USD 51.63 billion out of 2022 and is supposed to arrive at USD 113.46 billion by 2030 and develop at a CAGR of 10.34% over the forecast period 2023-2030.
Condensed Milk Market Size was esteemed at USD 8.29 billion out of 2022 and is supposed to arrive at USD 11.61 billion by 2030, and develop at a CAGR of 4.3% over the forecast period 2023-2030.
The Plant-based meat market is assessed to be esteemed at USD 7.38 billion by 2023 and is projected to arrive at USD 37.54 billion by 2032, recording a CAGR of 19.81% from 2024-2032.
The Non-Alcoholic RTD Beverages Market size was USD 931.1 billion in 2023 and is expected to Reach USD 1655.2 billion by 2032 and grow at a CAGR of 6.6 % over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
